DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MCAF5352A
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MCAF5352A
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IRGD
1
Unknown
Investigational
Unknown
Unknown
Carcinoma, Pancreatic Ductal
Unknown
IRGD
×
Maximum Phase:
1
First Approval:
None
UNII:
Z8MXU5GH4Q
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CEP-9722
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Mantle-Cell; Neoplasms
Unknown
CEP-9722
×
Maximum Phase:
1
First Approval:
None
UNII:
B68083E4YG
Molecule Type:
Small molecule
Molecular Formula:
C24H26N4O3
Molecular Weight:
418.5
AlogP:
2.62
PSA:
68.88
HBD:
1.0
HBA:
#RotB:
3.0
Source:
MDX-1342
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Leukemia, Lymphocytic, Chronic, B-Cell
B-lymphocyte antigen CD19 binding agent
MDX-1342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LOSATUXIZUMAB VEDOTIN
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
LOSATUXIZUMAB VEDOTIN
×
Maximum Phase:
1
First Approval:
None
UNII:
17C83BVV62
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALOFANIB
1
Small molecule
Investigational
Unknown
Unknown
Stomach Neoplasms
Unknown
ALOFANIB
×
Maximum Phase:
1
First Approval:
None
UNII:
LQX7RFK8MZ
Molecule Type:
Small molecule
Molecular Formula:
C19H15N3O6S
Molecular Weight:
413.41
AlogP:
3.46
PSA:
139.5
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NT-219
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NT-219
×
Maximum Phase:
1
First Approval:
None
UNII:
K1WT1A1UP5
Molecule Type:
Small molecule
Molecular Formula:
C16H14BrNO5S
Molecular Weight:
412.26
AlogP:
3.11
PSA:
113.18
HBD:
6.0
HBA:
#RotB:
4.0
Source:
UNESBULIN
1
Small molecule
Investigational
Unknown
Unknown
Diffuse Intrinsic Pontine Glioma; Leiomyosarcoma; Neoplasms; Ovarian Neoplasms
Unknown
UNESBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Z4HZ70S62Q
Molecule Type:
Small molecule
Molecular Formula:
C19H13F5N6
Molecular Weight:
420.35
AlogP:
4.75
PSA:
81.65
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SYM-022
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SYM-022
×
Maximum Phase:
1
First Approval:
None
UNII:
7TQ52FVC2L
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
APVO-414
1
Unknown
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
APVO-414
×
Maximum Phase:
1
First Approval:
None
UNII:
56JX9SY1PG
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SL-801
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SL-801
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LEMZOPARLIMAB
1
Antibody
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma
Unknown
LEMZOPARLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIO89-100
1
Unknown
Investigational
Unknown
Unknown
Hypertriglyceridemia; Non-alcoholic Fatty Liver Disease
Unknown
BIO89-100
×
Maximum Phase:
1
First Approval:
None
UNII:
UO870O6MFS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REBAUDIOSIDE A
1
Oligosaccharide
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
REBAUDIOSIDE A
×
Maximum Phase:
1
First Approval:
None
UNII:
B3FUD0528F
Molecule Type:
Oligosaccharide
Molecular Formula:
C44H70O23
Molecular Weight:
967.02
AlogP:
-5.11
PSA:
374.13
HBD:
14.0
HBA:
#RotB:
12.0
Source:
BEPECIN
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
BEPECIN
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELITRECTINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
SELITRECTINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
0J45910S3X
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O
Molecular Weight:
380.43
AlogP:
2.67
PSA:
75.42
HBD:
1.0
HBA:
#RotB:
0.0
Source:
PEGTIBATINASE
1
Enzyme
Investigational
Unknown
Unknown
Homocystinuria
Unknown
PEGTIBATINASE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HYDROXYNORKETAMINE, (2R,6R)
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HYDROXYNORKETAMINE, (2R,6R)
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H14ClNO2
Molecular Weight:
239.7
AlogP:
1.61
PSA:
63.32
HBD:
2.0
HBA:
#RotB:
1.0
Source:
MMV-390048
1
Small molecule
Investigational
Unknown
Unknown
Malaria; Malaria, Falciparum
Unknown
MMV-390048
×
Maximum Phase:
1
First Approval:
None
UNII:
0Z5T00JJ10
Molecule Type:
Small molecule
Molecular Formula:
C18H14F3N3O2S
Molecular Weight:
393.39
AlogP:
3.82
PSA:
85.94
HBD:
1.0
HBA:
#RotB:
3.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
MINT-1526A
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
MINT-1526A
×
Maximum Phase:
1
First Approval:
None
UNII:
H6BAM62K4Q
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MUPLESTIM
1
Protein
Investigational
Unknown
Unknown
HIV Infections
Unknown
MUPLESTIM
×
Maximum Phase:
1
First Approval:
None
UNII:
A802907MI4
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ORM-13070
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ORM-13070
×
Maximum Phase:
1
First Approval:
None
UNII:
X676C040B7
Molecule Type:
Small molecule
Molecular Formula:
C20H25N3O3
Molecular Weight:
355.44
AlogP:
2.19
PSA:
47.06
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PF-06671008
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
PF-06671008
×
Maximum Phase:
1
First Approval:
None
UNII:
2GWZ8HN70W
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBI-888
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBI-888
×
Maximum Phase:
1
First Approval:
None
UNII:
JI5TBH62QP
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK-7655
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
MK-7655
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BALAFILCON A
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BALAFILCON A
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK-1614235
1
Unknown
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
GSK-1614235
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
GSK-369796
1
Small molecule
Investigational
Unknown
Unknown
Malaria
Unknown
GSK-369796
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C20H22ClN3O
Molecular Weight:
355.87
AlogP:
5.23
PSA:
57.18
HBD:
3.0
HBA:
#RotB:
4.0
Source:
E7107
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
E7107
×
Maximum Phase:
1
First Approval:
None
UNII:
R60DZX1E2N
Molecule Type:
Small molecule
Molecular Formula:
C40H66N2O9
Molecular Weight:
718.97
AlogP:
5.05
PSA:
152.53
HBD:
4.0
HBA:
#RotB:
10.0
Source:
GSK-2239633
1
Small molecule
Investigational
Unknown
Unknown
Asthma
Unknown
GSK-2239633
×
Maximum Phase:
1
First Approval:
None
UNII:
07ODS257BP
Molecule Type:
Small molecule
Molecular Formula:
C21H19ClN4O5S2
Molecular Weight:
506.99
AlogP:
3.54
PSA:
122.55
HBD:
3.0
HBA:
#RotB:
8.0
Source:
DELANZOMIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Multiple Myeloma
Unknown
DELANZOMIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6IF28942WO
Molecule Type:
Small molecule
Molecular Formula:
C21H28BN3O5
Molecular Weight:
413.28
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ALT-801
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Melanoma; Multiple Myeloma; Neoplasms; Non-alcoholic Fatty Liver Disease; Urinary Bladder Neoplasms
Unknown
ALT-801
×
Maximum Phase:
1
First Approval:
None
UNII:
QWZ40O5W6K
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TIBULIZUMAB
1
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Sjogren's Syndrome
Interleukin 17A inhibitor
TIBULIZUMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
42HQ15W1ZF
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
89
90
91
92
93
94
95
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA